Core Findings - The study provides a detailed protein atlas of lysosomes in various brain cell types, identifying previously unannotated lysosomal proteins and revealing the diversity of lysosomal composition across different brain cell types [4][10][11] - SLC45A1, a neuron-specific lysosomal protein, is redefined as a lysosomal storage disorder (LSD) due to its mutation leading to significant lysosomal dysfunction [4][8][16] Lysosomal Function and Importance - Lysosomes are membrane-bound organelles responsible for degrading macromolecules and clearing damaged organelles, crucial for maintaining cellular homeostasis [6] - They play a key role in nutrient and energy sensing pathways, impacting cellular metabolism and are involved in various cellular functions such as membrane repair and programmed cell death [6] Research Methodology - The research utilized a LysoTag mouse model combined with cell-type specific Cre recombinase expression to generate a comprehensive lysosomal protein map covering major brain cell types, including neurons, astrocytes, oligodendrocytes, and microglia [8][11] - The study highlights the impact of SLC45A1 on the stability of the V-ATPase complex on lysosomal membranes, linking its deficiency to impaired lysosomal acidification and mitochondrial dysfunction [4][8][16] Implications for Future Research - This research lays the groundwork for future studies on lysosomal biology and its role in neurodegenerative diseases, emphasizing the need to explore the specific functions of different lysosomal proteins in various brain cell types [11]

Core Insights - The study indicates that Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a diurnal disease influenced by multi-system insulin resistance and reduced insulin availability at night [3][9] - The severity of MASLD and related metabolic disorders exhibits significant diurnal fluctuations, with nighttime being the period of most severe metabolic issues, providing new insights for optimal timing of diet, exercise, and medication for patients [3][12] Summary by Sections - **Introduction to MASLD**: MASLD affects approximately 40% of the global population and is closely linked to obesity and insulin resistance (IR). It is characterized by excessive triglyceride (TAG) accumulation in liver cells, which can progress to Metabolic Dysfunction-Associated Steatotic Hepatitis (MASH), cirrhosis, and hepatocellular carcinoma [5] - **Mechanisms of MASLD**: The pathogenesis of MASLD depends on the imbalance between lipid influx and synthesis versus clearance in the liver. TAG in the liver originates from fatty acid esterification, which can come from fat tissue breakdown, dietary intake, or de novo lipogenesis (DNL) [5] - **Circadian Influence on Metabolism**: Preclinical models show that liver metabolic homeostasis is strongly influenced by biological clocks, which synchronize physiological functions and behaviors over a 24-hour cycle. Disruption of these rhythms can lead to adverse metabolic outcomes, including liver steatosis [6] - **Research Findings**: The study analyzed diurnal metabolic phenotypes in MASLD patients and overweight controls using advanced stable isotope techniques. Key findings include significant nighttime metabolic dysfunction in MASLD, with activated pathogenic pathways such as hepatic and peripheral insulin resistance, DNL, and systemic NEFA exposure [7][9] - **Persistent Nighttime Dysfunction**: Even after weight loss and reduction of liver fat, nighttime metabolic dysfunction persists, suggesting it may be a primary driver of steatosis [8] - **New Treatment Strategies**: The research suggests a new therapeutic approach—time therapy. This includes scheduling most caloric intake during the day when insulin sensitivity is higher, exercising during less favorable metabolic periods, and adjusting medication timing based on the disease's circadian characteristics to maximize efficacy [12]

Core Insights - A groundbreaking study published in *Science* identifies a new type of neural stem cell in the human brain that continuously produces inhibitory neurons during the embryonic stage, essential for brain development [1] Group 1 - The research was conducted by a collaboration between Tsinghua University's Mida team and Academician Zhu Lan's team from the Chinese Academy of Medical Sciences, Peking Union Medical College Hospital [1] - The discovery addresses the long-standing mystery of how the human brain generates a reservoir of inhibitory neurons [1]

Core Viewpoint - The research highlights the role of the fungal commensal Kazachstania pintolopesii (Kp) in promoting intestinal repair through its secreted peptide, CD12, marking a significant advancement in understanding gut regeneration mechanisms and positioning gut fungi as potential biotherapeutics for inflammatory and iatrogenic bowel diseases [3][7]. Group 1 - The study confirms that the secreted protein Ygp1 from Kp plays a crucial mediating role in intestinal regeneration [6]. - A 12-amino acid peptide fragment, CD12, derived from Ygp1, is sufficient to promote differentiation of intestinal organoids and accelerate gut healing in mouse models of colitis and chemotherapy-induced damage [6]. - CD12 interacts with mammalian α-enolase (ENO1), increasing YAP1 protein levels and activating regeneration-related transcriptional programs via the Hippo signaling pathway [6]. Group 2 - The research provides a translatable delivery strategy by demonstrating that engineered probiotics expressing CD12 can replicate its therapeutic benefits [6].

Core Insights - The research published in Cell journal reveals the atomic structure of human islet amyloid polypeptide (hIAPP) fibrils extracted from type 2 diabetes patients, marking a significant advancement in understanding the disease mechanism and potential therapeutic targets [1][2][14]. Group 1: Research Findings - The study identifies a unique "Ω-shaped folding" of hIAPP, which is crucial in the pathology of type 2 diabetes, as it leads to the formation of amyloid fibrils that damage insulin-secreting β-cells [3][6]. - The research team utilized cryo-electron microscopy to directly observe the hIAPP fibrils from patient samples, confirming a highly uniform structure compared to the polymorphic forms seen in vitro [4][6]. - The study highlights the presence of six additional electron density regions in the structure, suggesting the involvement of other molecules (ligands) that stabilize the hIAPP fibrils [7][9]. Group 2: Implications for Diagnosis and Treatment - The findings provide a new understanding of the disease mechanism, proposing that unknown ligands, possibly lipids, play a critical role in driving the pathological folding of hIAPP [9][10]. - The research indicates a structural similarity between hIAPP fibrils and amyloid-beta (Aβ) fibrils found in Alzheimer's disease, suggesting a potential link between the two diseases and the possibility of developing treatments targeting both conditions [10][13]. - The study opens avenues for early diagnosis through the development of molecular imaging probes that can detect hIAPP deposits before clinical symptoms appear, as well as targeted therapies that could disrupt hIAPP fibril formation [13][14].

Core Viewpoint - The article discusses a groundbreaking study published in Nature that challenges the traditional understanding of nutrient availability in cancer cell metastasis, suggesting that the interaction between multiple nutrients and the intrinsic characteristics of cancer cells plays a crucial role in determining metastatic behavior [2][3][4]. Group 1: Research Findings - The study quantified the absolute levels of 124 metabolites in various organs of mice and explored their relationship with breast cancer cell growth in different tissues [3]. - It was found that the availability of a single nutrient does not dictate the metastatic site for breast cancer cells; rather, the complex interplay of multiple nutrients and tumor characteristics influences metastatic outcomes [4]. - The research established that purine synthesis is essential for tumor growth and metastasis across various tissues, independent of nucleotide availability or tumor nucleotide synthesis activity [3][4]. Group 2: Nutrient Mapping - The research team created a detailed "nutrient map" of multiple organs in mice, revealing significant differences in nutrient environments between tissues, with many metabolites being more concentrated in tissue interstitial fluids than in plasma [7]. - Nucleotide and related metabolites were identified as the primary factors causing inter-organ differences, rather than amino acids, indicating that variations in nucleotide supply may significantly impact cancer cell colonization [7]. Group 3: Engineered Cancer Cells - The study utilized gene editing to create breast cancer cell lines that required external supplementation of specific nutrients, focusing on triple-negative breast cancer cells [10]. - These engineered cells lost the ability to synthesize certain nutrients and could only proliferate when those nutrients were provided externally [10]. Group 4: Unexpected Results - Upon injecting these modified cancer cells into mice, the results were surprising; despite significant differences in nutrient levels across tissues, the growth ability of nutrient-deficient cells did not follow a consistent pattern [12]. - The study highlighted that while purine synthesis pathways were essential for all tested cell lines and tissues, amino acid dependencies exhibited notable cell line and tissue specificity [12]. Group 5: Metabolic Insights - The research employed carbon-13 labeled glucose to track tumor cell metabolic activity, revealing significant metabolic differences between brain tumors and tumors in breast adipose tissue [15]. - Increased amino acid synthesis activity in brain tumors did not always correlate with reliance on the corresponding synthesis pathways, suggesting cancer cells can adapt to various nutrient environments through multiple mechanisms [15]. Group 6: Clinical Implications and Future Directions - The findings have significant implications for understanding cancer metastasis mechanisms and developing treatment strategies, explaining the limited clinical efficacy of therapies targeting single metabolic pathways [17]. - The study suggests that future cancer treatments may need to target multiple metabolic pathways or be personalized based on specific tumor characteristics and metastatic locations, with potential applicability to other cancer types beyond breast cancer [18].

Core Viewpoint - The article discusses the rising global obesity rates and highlights the potential of cysteine-restricted diets as an intervention method, focusing on the molecular mechanisms behind rapid weight loss induced by cysteine limitation [8][9]. Research Background and Purpose - Background: The global obesity prevalence is increasing, and cysteine-restricted diets are gaining attention as a potential intervention method. Cysteine is a crucial precursor for synthesizing glutathione (GSH) and coenzyme A (CoA), but the specific effects of cysteine limitation on body weight and its regulatory mechanisms remain unclear [8]. - Purpose: The study aims to explore the molecular mechanisms behind rapid weight loss induced by cysteine restriction using mouse experiments, providing new targets for obesity treatment [9]. Research Methods - Study Design: The research utilized Cse gene knockout (KO) and wild-type (WT) mice, administering cysteine-restricted diets (no-Cys) and other essential amino acid-restricted diets, combined with metabolic cage monitoring and comprehensive transcriptomic and metabolomic analyses [10]. - Data Sources: The study collected metabolic products from mouse liver, muscle, fat tissues, serum, and urine, with sample sizes ranging from 3 to 9 mice per experimental group [11]. - Research Variables: The focus was on cysteine intake, body weight changes, and metabolic indicators such as GSH, CoA, and inflammatory factors [12]. - Analysis Methods: Techniques included RNA sequencing, LC-MS metabolomics, immunohistochemistry, Western blotting, and indirect energy metabolism measurement [13]. Research Results 1. Cysteine deficiency leads to rapid and reversible weight loss: Cse KO mice on a no-Cys diet experienced a weight loss of up to 30% within one week, significantly exceeding other essential amino acid-restricted groups. Weight returned to baseline upon resuming normal diet, indicating that weight loss was primarily due to cysteine deficiency [14]. 2. Metabolic reprogramming promotes fat consumption and browning: The no-Cys diet reduced the respiratory exchange ratio (RER) and total fat mass, with a notable increase in UCP1-positive cells in white adipose tissue, indicating brown fat characteristics. Liver transcriptomic results showed activation of fatty acid oxidation pathways and suppression of fat synthesis genes [16]. 3. Integration of stress pathways and oxidative stress: Cysteine restriction activated integrated stress response (ISR) and oxidative stress response (OSR), significantly increasing serum levels of GDF15 and FGF21. Deletion of Gdf15 or Fgf21 slowed weight loss, suggesting their roles in metabolic adaptation regulation [19]. 4. CoA reduction leads to decreased metabolic efficiency: The no-Cys diet lowered liver CoA levels, resulting in increased urinary excretion of TCA cycle intermediates, indicating impaired mitochondrial oxidative phosphorylation capacity [20][21]. 5. Tissue-specific regulation of energy metabolism pathways: ISR and OSR-related genes were significantly upregulated in the liver, while muscle primarily activated oxidative stress pathways, and adipose tissue emphasized lipolysis and browning responses, demonstrating coordinated regulation across multiple tissues for systemic metabolic remodeling [23]. Research Conclusion and Limitations - Conclusion: Cysteine restriction promotes rapid weight loss by depleting GSH and CoA, activating stress responses, enhancing fat oxidation, reducing metabolic efficiency, and stimulating creatine cycling compensation. This physiological process is reversible and offers new insights for obesity treatment [27]. - Limitations: The study has not assessed the safety of cysteine restriction in humans, and the long-term effects on other organs and gender differences remain unexplored, necessitating further validation of the underlying mechanisms [28]. Future Research Directions - Future studies should evaluate the weight loss effects and safety of cysteine restriction in primates, analyze the impact of cysteine deficiency on gut microbiota, and explore the molecular mechanisms of gender differences in response to cysteine restriction to advance personalized intervention strategies [29].

Core Viewpoint - Gastric cancer (GC) is the fifth most common cancer globally and a leading cause of cancer-related deaths, with China accounting for nearly 50% of the world's cases despite having only 20% of the global population [3] Group 1: Research Findings - Helicobacter pylori is a major risk factor for gastric cancer, but only 1%-3% of infected individuals develop the disease, indicating other contributing factors [3] - Recent studies by teams from Hong Kong Chinese University and Shanghai Jiao Tong University have identified Streptococcus anginosus as a promoter of gastric cancer through its metabolic product, methionine [3][5] - The research published in the journal Gut demonstrates that S. anginosus enhances gastric cancer progression, providing new insights for potential personalized treatment targets [3][5] Group 2: Methodology and Results - The research utilized shotgun metagenomic sequencing to explore the interaction between S. anginosus and the host, confirming its pro-inflammatory effects [5] - Experiments showed that the abundance of S. anginosus in gastric cancer patients correlates with a significant enrichment of the methionine biosynthesis pathway [5] - The study identified metE gene as crucial for methionine biosynthesis, with higher abundance observed in cancerous tissues, further validated by constructing a mutant strain of S. anginosus lacking the metE gene [5]

Core Insights - The article emphasizes the role of the bed nucleus of the stria terminalis (BNST) as a central hub in the brain that regulates feeding behavior by integrating sensory inputs and internal states, providing a unified command for eating actions [17]. Summary by Sections Taste System and Feeding Behavior - The taste system acts as the primary sensory gateway for regulating eating behavior, with specialized taste receptor cells (TRC) identifying taste signals and transmitting information to the taste cortex [7]. - The brain's mechanism for converting sweet taste signals into actual eating behavior remains incompletely understood, despite advancements in sensory biology [7]. Brain Circuitry and Hunger Regulation - Research has identified complex neural networks, including AGRP and POMC neurons, that regulate hunger and feeding, suggesting a universal "feeding control center" in the brain [8]. - The BNST has been identified as a key brain region that integrates internal states and sensory signals, playing a crucial role in the unified regulation of feeding behavior [8]. Neuronal Response to Sweetness - Neurons in the central amygdala (CEA) that respond to sweetness have been characterized, with over 90% of sweet-responsive neurons co-expressing preproenkephalin (Pdyn) [9]. - Activation of Pdyn neurons in the CEA can make mice perceive regular water as an attractive stimulus, while inhibiting these neurons eliminates their preference for sweet substances [9]. BNST's Role in Feeding Response - The CEA-Pdyn neuron pathway projects densely to the BNST, which is critical for mediating sweet-induced feeding responses [10]. - Hunger increases sweet consumption by 2.5 times in mice, with BNST activity enhancing the response to sweetness during hunger [10]. Integration of Signals in BNST - The BNST receives projections from both sweet-responsive neurons in the CEA and hunger-signaling AGRP neurons, allowing it to enhance responses to sweetness and regulate feeding behavior [11]. - In sodium deficiency, BNST's response to salty stimuli increases by 300%, demonstrating its role in integrating various signals for precise feeding regulation [11]. Neuronal Activity and Internal States - BNST neurons can distinguish between different "stimulus-internal state" combinations, with a prediction accuracy of 80% for these combinations [12]. - The number of sweet-responsive neurons in the BNST increases by 40% during hunger, indicating a dynamic response to internal states [12]. Comprehensive Control of Feeding Behavior - Activation of the BNST leads to increased feeding impulses, even for normally avoided substances, while inhibition reduces food intake regardless of hunger or sodium deficiency [14]. - The BNST's ability to control various feeding behaviors suggests it is not limited to specific food types but serves as a general feeding control center [14]. Bidirectional Weight Regulation - The BNST has been shown to regulate body weight in both cachexia and obesity models, with selective activation delaying weight loss by 30% and inhibition leading to an 8% weight reduction comparable to GLP-1 receptor agonists [15][16]. - These findings indicate that the BNST is a potential target for interventions in weight management, particularly in addressing both obesity and cachexia [16]. Conclusion - The BNST is confirmed as the central command center for feeding behavior, integrating sensory inputs and internal states to flexibly adjust feeding preferences and intake [17]. - This discovery provides new insights into the mechanisms of appetite regulation and potential therapeutic targets for obesity and related disorders [17].

Core Findings - The study confirms that VHL protein is a true regulator of mitochondrial metabolism under hypoxic conditions, rather than merely serving as a "backup adapter" for hypoxia-inducible factors (HIF) in low oxygen environments [5]. Group 1: Research Insights - Under chronic hypoxia, most cytoplasmic VHL protein degrades, while the remaining VHL protein primarily relocates to mitochondria [2] - Mitochondrial VHL binds and inhibits a key component of the leucine metabolism pathway, MCCC2, leading to leucine accumulation and activation of glutamate dehydrogenase, which promotes glutamine hydrolysis to generate sufficient lipids and nucleotides for hypoxic cell growth [2] - SRC-mediated phosphorylation of VHL and PRMT5-mediated methylation of MCCC2 can synergistically regulate the VHL-MCCC2 interaction and its accompanying metabolic reprogramming [2] Group 2: Mechanisms and Implications - The study demonstrates that low oxygen-dependent post-translational modifications regulate the interaction between VHL and MCCC2 [6] - Mitochondrial VHL plays a crucial role in the body's adaptive response to pathological hypoxia [6]